Article
TERT mutation in glioma: Frequency, prognosis and risk.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia - 1 Apr 2016
Yuan Yang, Qi Chen, Maling Gou, Xiang Wang, Yanhui Liu, Ruofei Liang, Yunhe Mao, Jiewen Luo, Qing Mao
Abstract excerpt
Telomerase reverse transcriptase (TERT) has received a great deal of attention in recent years for its role as a prognostic and predictive molecular marker of glioma. However, the results of studies examining its mutation frequency and predictive value are inconsistent, and several studies have investigated the association between TERT gene polymorphisms and gliomagenesis. We used a meta-analysis approach to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
